Human Microbiota and Liver Transplant
Prospective Study To Characterize The Human Microbiota In Liver Transplantation And Its Impact On Early Outcome
Sponsor: Hospital Vall d'Hebron
This observational or N/A phase trial investigates Acute Rejection of Liver Transplant and Complication of Transplanted Liver and is currently completed. Hospital Vall d'Hebron leads this study, which shows 13 recorded versions since 2016 — indicating substantial longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.
Status Flow
Change History
13 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Dec 2021 — Jul 2024 [monthly]
Completed
-
Sep 2021 — Dec 2021 [monthly]
Completed
Status: Recruiting → Completed
-
Jan 2021 — Sep 2021 [monthly]
Recruiting
▶ Show 8 earlier versions
-
Nov 2020 — Jan 2021 [monthly]
Recruiting
-
Mar 2020 — Nov 2020 [monthly]
Recruiting
-
Mar 2019 — Mar 2020 [monthly]
Recruiting
-
Jun 2018 — Mar 2019 [monthly]
Recruiting
-
May 2018 — Jun 2018 [monthly]
Recruiting
-
Apr 2018 — May 2018 [monthly]
Recruiting
Phase: NA → None
-
Aug 2017 — Apr 2018 [monthly]
Recruiting NA
-
Jan 2017 — Aug 2017 [monthly]
Recruiting NA
First recorded
Jan 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Hospital Vall d'Hebron
For direct contact, visit the study record on ClinicalTrials.gov .